Navigation Links
FDA Approves First Drug to Prevent Premature Births
Date:2/7/2011

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 4 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first drug to help prevent premature birth in women who have had at least one previous preterm delivery.

The drug -- called Makena (hydroxyprogesterone caproate) -- is expected to reduce the risk of premature delivery, which experts say raises the risk of infant complications at birth, lifelong disabilities such as cerebral palsy, and even death.

Preterm delivery is a serious problem in the United States, FDA spokeswoman Shelly Burgess said.

According to the March of Dimes, preterm birth -- or the birth of a baby at less than 37 completed weeks of pregnancy -- affects one in eight babies born in the United States, she noted.

What's more, the rate of preterm birth has increased more than 35 percent in the last 25 years in the United States, and late preterm births -- babies born at 34 to 36 weeks of pregnancy -- account for nearly three-quarters of such births, Burgess said.

Makena will reduce the risk of preterm delivery before 37 weeks of gestation in pregnant women with a history of at least one spontaneous preterm birth, Burgess noted.

She added that Makena is approved for a certain subset of all U.S. women at risk for preterm birth: those carrying one baby (known as a "singleton pregnancy") who previously gave birth prematurely to one baby.

According to the agency, the drug is not intended to be used by women having twins or other risk factors for preterm birth.

The March of Dimes applauded the FDA's decision.

"The most common risk factor for preterm birth is recurrence," said Dr. Alan Fleischman, March of Dimes senior vice president and medical director. "This is the first approved drug to prevent recurrence for women who have had a singleton preterm baby and now have a singleton baby," he added. "That will dramatically [lower the] rate for
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Swiss agency approves clinical trial of UCI-created neural stem cell therapy
2. ACGME board approves final duty hour and supervision standards for resident education
3. FDA Approves 1st Oral Drug to Reduce MS Relapses
4. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
5. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
6. FDA approves first human neural stem cell clinical trial to treat brain tumors
7. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
8. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
9. House of Representatives Approves Health-Care Reform Bill
10. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
11. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves First Drug to Prevent Premature Births 
(Date:8/3/2015)... ... August 03, 2015 , ... Results ... Navigant Center for Healthcare Research and Policy Analysis show widespread support for the ... said they agreed or strongly agreed that the controversial law passed in 2010 ...
(Date:8/3/2015)... ... August 03, 2015 , ... It’s 25 miles from ... California’s northernmost and among its least visited State Parks. The volcanic area beneath ... outflow is at Ahjumawi Lava Springs, part of the Fall River Springs complex. ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... AZ (PRWEB) , ... August 03, 2015 , ... Dignity ... Dignity Health Arizona General Hospital Emergency Room – Gilbert, opening in August. The ... earlier this year in the West Valley. , “Dr. Baldwin is an excellent ...
(Date:8/3/2015)... ... 2015 , ... Cambia Health Solutions has promoted Scott Powers ... Medicare and Federal Employee Programs (FEP) lines of business. , Government programs ... In this role, Scott is responsible for overseeing the growth, finance and operations ...
Breaking Medicine News(10 mins):Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2
... Pharmasset, Inc.,(Nasdaq: VRUS ) management will present ... being held from May 19-20, 2008 at the Le,Meridien ... Chief Executive Officer, will provide an overview of the,company ... in the Zephyr Salon., To access a simultaneous ...
... Foundation to celebrate,scientific advancements that have fueled longer life ... To celebrate,remarkable progress in treating cystic fibrosis -- ... the Cystic Fibrosis Foundation,to join the company as honored ... Life expectancy for people with CF has more than ...
... Company Prepares for, Potential 2008 Launch of MOXATAG; Keflex Product Sales ... ... in Quarter, GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... anti-infective products, today,announced financial and operational results for the quarter ended ...
... impact EPA,s clean air regulations, researchers say , , TUESDAY, ... particles, such as those found in windblown dust or ... not appear to be linked to hospital admissions, a ... for short, is between 2.5 and 10 micrometers or ...
... studies report, , , TUESDAY, May 13 (HealthDay News) -- New ... breast cancer risk. , The bad news is a ... with breast cancer face an increased risk of breast cancer ... according to a study in the May 13 issue of ...
... used to treat a rare but well-known genetic disorder may ... with potentially lethal enlarged hearts, due mainly to high blood ... The common denominator in both phenylketonuria (PKU) and cardiac hypertrophy ... coworker helps break down the molecule phenylalanine whose buildup is ...
Cached Medicine News:Health News:Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th 2Health News:Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:No Link Between Coarse Air Pollution, Hospitalizations 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4
(Date:8/3/2015)... Ill. , Aug. 3, 2015 Your ... problem, and you,re looking for the best possible outcome. ... the best outcome too, and now there,s a ... Following steps recommended by the American Orthopaedic Foot ... surgery can help you avoid complications and heal as ...
(Date:8/3/2015)... , Aug. 3, 2015 Par Pharmaceutical ... conference call on Friday, August 7, 2015 at 9:00 ... the second quarter ended June 30, 2015.  Par is ... to the public in its filings with the Securities ... available on its website by following the instructions at ...
(Date:8/3/2015)... N.J. , Aug. 3, 2015 Ortho ... has been named Chief Corporate Brand and Communications ... firm,s executive leadership team, Bouryal will lead the company,s ... builds on its transition to an independent company by ... report to Chairman and Chief Executive Officer Dr. ...
Breaking Medicine Technology:Patient Guide: How to Prepare for Surgery 2Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
... 22 Dynavax,Technologies Corporation (Nasdaq: DVAX ) today ... ragweed allergy therapy, to subjects as,part of an environmental ... of 300 subjects. Subjects are being screened based on ... Exposure to ragweed allergen in,the chamber is being used ...
... 22 Boston,Scientific Corporation (NYSE: BSX ) ... which continue to support the proven safety and,efficacy ... and add to the growing body of strong ... Coronary,Stent System. An analysis of the data was ...
Cached Medicine Technology:Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 2Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 3Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 4
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... Family offers fast temperature control, exact block ... Personal cards enable safe program storage as ... individual protocols between different Mastercyclers. All models ... come with a two-year warranty. The ...
... 96 well thermocycler with ... Peltier technology for fastest available ... to 4C/sec with High Pressure ... PCR plates. Includes motorized ...
... graphical touch screen display which enables you ... of a screen." Features & Benefits ... Graphical Display, Memory Cards, Gradient Calculator, Fold ... Programmin, Free Instrument Software Upgrade. Includes ...
Medicine Products: